Search Results - "TANSWELL, Paul"
-
1
Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats
Published in Drug metabolism and disposition (01-10-2014)“…Transporter gene knockout rat models are attracting increasing interest for mechanistic studies of new drugs as transporter substrates or inhibitors in vivo…”
Get full text
Journal Article -
2
Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction
Published in Clinical pharmacokinetics (2002)“…Tenecteplase is a novel fibrinolytic protein bioengineered from human tissue plasminogen activator (alteplase) for the therapy of acute ST-segment elevation…”
Get full text
Journal Article -
3
A Phase I Dose-Escalation Study of Sibrotuzumab in Patients with Advanced or Metastatic Fibroblast Activation Protein-positive Cancer
Published in Clinical cancer research (01-05-2003)“…Purpose: The purpose of this research was to determine the safety, immunogenicity, pharmacokinetics, biodistribution, and tumor uptake of repeat infusions of a…”
Get full text
Journal Article -
4
Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects
Published in British journal of clinical pharmacology (01-07-2004)“…Aims To characterize the pharmacokinetics of terbogrel, a new combined thromboxane A2 (TxA2) receptor and synthase inhibitor, in healthy human subjects after…”
Get full text
Journal Article -
5
Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction
Published in The American journal of cardiology (01-09-1989)“…Recombinant tissue-type plasminogen activator (rt-PA) has hitherto been administered in acute myocardial infarction as an intravenous infusion with an initial…”
Get full text
Journal Article -
6
Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species: a comparison of mathematical models
Published in Biopharmaceutics & drug disposition (01-03-1998)“…A recent study presented plasma concentrations of tissue‐type plasminogen activator in three different animal species and at several different dose levels. A…”
Get full text
Journal Article -
7
-
8
Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients
Published in British journal of clinical pharmacology (01-02-2001)“…Aims The population pharmacokinetics of 131I‐mAbF19, a radiolabelled murine monoclonal antibody against fibroblast activation protein and a potential…”
Get full text
Journal Article -
9
Pharmacokinetics and Pharmacodynamics of Tenecteplase: Results from a Phase II Study in Patients with Acute Myocardial Infarction
Published in Journal of clinical pharmacology (01-05-2000)“…Tenecteplase is a site‐specific engineered tissue plasminogen activator (t‐PA) variant that can be administered as a single intravenous bolus injection because…”
Get full text
Journal Article Conference Proceeding -
10
Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction
Published in Journal of the American College of Cardiology (01-04-1992)“…Pharmacokinetics and fibrin specificity of alteplase (recombinant tissue-type plasminogen activator) were determined in 10 patients with acute myocardiol…”
Get full text
Journal Article -
11
Sixty-Minute Alteplase Protocol: A New Accelerated Recombinant Tissue-Type Plasminogen Activator Regimen for Thrombolysis in Acute Myocardial Infarction
Published in Journal of the American College of Cardiology (01-12-1997)“…Objectives. Our aim was to design and evaluate a new and easily administered recombinant tissue-type plasminogen activator (rt-PA) regimen for thrombolysis in…”
Get full text
Journal Article -
12
Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects
Published in Clinical pharmacology and therapeutics (01-08-1989)“…Pharmacokinetics and systemic effects of recombinant tissue-type plasminogen activator (rt-PA) were studied in 18 healthy male volunteers after 30-minute…”
Get more information
Journal Article -
13
A selective radioimmunoassay for the determination of pirenzepine in plasma and urine
Published in Therapeutic drug monitoring (01-06-1987)“…A radioimmunoassay procedure for the determination of pirenzepine in either plasma or urine was demonstrated to be both sensitive and specific as well as…”
Get more information
Journal Article -
14
Nuclear-magnetic-resonance study of the active-site structure of yeast phosphoglycerate kinase
Published in European journal of biochemistry (01-01-1976)“…The enzyme 3‐phosphoglycerate kinase from yeast has been studied by observation of the proton nuclear magnetic resonance spectrum at 270 MHz using Fourier…”
Get full text
Journal Article -
15
Immunological approaches to the structure of fibrinogen
Published in Thrombosis and haemostasis (01-01-1979)Get more information
Journal Article -
16
Structure of antigenic determinants in the amino-terminal region of bovine fibrinogen alpha chain
Published in European journal of biochemistry (01-01-1978)“…A radioimmunoassay was developed for peptide F‐CB1α from the amino end of bovine fibrinogen Aα chain, isolated after reduction and carboxymethylation of the…”
Get full text
Journal Article -
17
Quantitative Determination of the Conformation of ATP in Aqueous Solution Using the Lanthanide Cations as Nuclear‐Magnetic‐Resonance Probes
Published in European journal of biochemistry (01-09-1975)“…Chemical shift perturbations of the eight 1H resonances and of the three 31P resonances in the nuclear magnetic resonance spectra of ATP in 2H2O, pH 6.0, have…”
Get full text
Journal Article -
18
Immunochemistry of bovine fibrinogen--III. Localization of two antigenic determinants in fibrinopeptide B
Published in Immunochemistry (1965) (1977)Get more information
Journal Article